The following industry symposium takes place at the 2018 AAHKS Annual Meeting:
Friday, November 2, 2018
10:00 a.m. – 12:00 p.m.
Localized Treatment for Osteoarthritis Knee Pain with a Novel Intra-Articular Formulation
Osteoarthritis of the knee (OAK) is increasing in prevalence with patients being diagnosed earlier and living longer with pain. With the increasing impact of OAK, it becomes increasingly important for clinicians to have treatment options along the disease continuum to alleviate the joint pain that is a hallmark of OAK.
This program will introduce ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), the first and only FDA-approved intra-articular treatment for OAK pain utilizing extended-release microsphere technology.